Alpha 2.0
Login Register
» Articles » PMID: 21277543

Retraction--Validation of Gene Signatures That Predict the Response of Breast Cancer to Neoadjuvant Chemotherapy: a Substudy of the EORTC 10994/BIG 00-01 Clinical Trial

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2011 Feb 1
PMID 21277543
Citations 4
Authors
Herve Bonnefoi
Anil Potti
Mauro Delorenzi
Louis Mauriac
Mario Campone
Michele Tubiana-Hulin
Thierry Petit
Philippe Rouanet
Jacek Jassem
Emmanuel Blot
Veronique Becette
Pierre Farmer
Sylvie Andre
Chaitanya R Acharya
Sayan Mukherjee
David Cameron
Jonas Bergh
Joseph R Nevins
Richard D Iggo
Affiliations
Soon will be listed here.
Citing Articles

Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.

He D, Wu X, Lu C, Gu X, Zhang G, Ma X Oncol Rep. 2017; 38(6):3392-3402.

PMID: 29039577 PMC: 5783585. DOI: 10.3892/or.2017.6033.

Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.

Pourteimoor V, Mohammadi-Yeganeh S, Paryan M Tumour Biol. 2016; 37(11):14479-14499.

PMID: 27651157 DOI: 10.1007/s13277-016-5349-7.

Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.

Fowles J, Brown K, Hess A, Duval D, Gustafson D BMC Bioinformatics. 2016; 17:93.

PMID: 26892349 PMC: 4759767. DOI: 10.1186/s12859-016-0942-8.

Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.

Trinh X, Tjalma W, Dirix L, Vermeulen P, Peeters D, Bachvarov D PLoS One. 2011; 6(7):e22469.

PMID: 21799864 PMC: 3143137. DOI: 10.1371/journal.pone.0022469.